Created at 8:24 a.m. Jun, 01, 2025
Author: haruharu
Related Note: 1531956908372 2
Rationale for change

Per AMBOSS, Carvedilol is the preferred non-selective B-blocker.
https://next.amboss.com/us/article/Zs0Zth?q=esophageal%20varices#kjWm0l0

Additionally:
According to a Swedish source, it seems that since the Baveno-meeting of 2022 (Baveno VII) carvelilol is preferred for all patients with compensated cirrhosis with a elastographic value of >25 kPa (as measured by Fibroscan) regardless if the patient has varices or not. The reasoning for this is that it in addition to preventing variceal bleeding also prevents decompensation.

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Other::!AK_UpdateTags::step2PotentialDupes::Forrest::Combine_haveValue #AK_Step2_v12::#UWorld::COMLEX::28731 #AK_Step1_v12::#OME::04_Organ_Systems::01_Cardiology::01_Hemodynamics::06_Hypertension_Pharmacology #AK_Step2_v12::#B&B::06_GI::02_Liver::03_Cirrhosis #AK_Step2_v12::#OME::01_Medicine::03_Gastroenterology::12_Cirrhosis #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::01_Cardiology::01_Hemodynamics::06_Hypertension_Pharmacology #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::16_Beta_Adrenergic_Antagonists #AK_Step2_v12::#AMBOSS::e30xhf #AK_Step2_v12::#UWorld::Step::11359 #AK_Step1_v12::#OME::04_Organ_Systems::03_Gastrointestinal::03_Hepatobiliary::05_Cirrhosis #AK_Step1_v12::#Pixorize::03_Pharmacology::24_Alpha_&_Beta_Blockers_(New)::08_Clinical_Use_of_Beta_Blockers #PANCE::EOR::Surgery #AK_Step2_v12::#SketchyIM::11_Hepatobiliary::03_Cirrhosis::02_Cirrhosis_Complications_&_Management #AK_Step2_v12::#SketchyIM::10_Gastroenterology::05_GI_Bleeding::01_Acute_Upper_GI_Bleed:_Esophageal_Varices #AK_Step2_v12::#AMBOSS::0waeh5 #AK_Step1_v12::#Bootcamp::Gastroenterology::05_Liver::18_Portal_HTN_Presentation_and_SAAG #AK_Step2_v12::!FLAG_THESE_CARDS::Potential_duplicates #AK_Step2_v12::#UWorld::COMLEX::102309 #AK_Step1_v12::#Pixorize::03_Pharmacology::24_Alpha_&_Beta_Blockers_(New)::05_Nonselective_Beta_Blockers #AK_Step2_v12::#Subjects::Gastroenterology::09_Liver::Cirrhosis::Complications::Esophageal_Varices #AK_Step1_v12::#Bootcamp::Gastroenterology::03_Esophagus::10_Esophageal_Barotrauma_and_Bleeding #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::#OME::01_Medicine::03_Gastroenterology::13_Cirrhosis_Complications #AK_Step2_v12::#Subjects::Gastroenterology::09_Liver::Cirrhosis::Complications::Esophageal_Varices::Screening_&_Prophylaxis #PANCE::EOR::Family_med #AK_Step2_v12::#Resources_by_rotation::Surgery::amboss::dorian::gi #PANCE::EOR::IM #PANCE::GI::esophageal_disorders #AK_Step2_v12::#AMBOSS::dw0o3R #AK_Step2_v12::#Resources_by_rotation::IM::ome::gi::cirrhosis+complications #AK_Step2_v12::!Shelf::Surgery #AK_Step2_v12::#UWorld::Step::2921 #AK_Step1_v12::#Pixorize::03_Pharmacology::05_Alpha_&_Beta_Blockers::05_Combined_Alpha-Beta_Blockers_(Carvedilol,Labetalol) #AK_Step3_v12::#UWorld::6037 #PANCE::EOR::EM #AK_Step2_v12::#UWorld::Step::12514 #AK_Step2_v12::#B&B::02_Cardio::05_Pharm::01_Cardiovascular_Pharmacology_I #AK_Step2_v12::Original_decks::Dorian::surg::amboss::gi